2023 Pre-Conference Workshop I
Sunday, May 14, 2023
(tentative time)
Psychedelic Patents—Avoiding Controversy While Achieving Defensible and Enforceable IP
Most will agree that patents are necessary for drug development, because without the reward of exclusivity, the investment in trials can be impossible to justify, and new drugs may never reach the market. But how can strong IP be built around known psychedelic compounds, or even variations of them, especially in a crowded field with many close competitors, with significant uncertainties around REMS—and in view of controversies around whether patents should be granted on psychedelics at all? How can a patent strategy be best designed to account for these difficulties, while taking advantage of regulatory exclusivities and other incentive mechanisms to bring innovative therapeutics into the clinic and to patients?





As practitioners, our goal is to be the foremost experts and most sought-out advocates on patent and IP issues central to emerging cutting-edge technologies. Founded in 2016, we were the first patent law boutique in California to focus on the cannabis industry, and we were among the first patent professionals anywhere to work on psychedelics.